Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SRC kinase signaling inhibitor 1 (SRCIN1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the SRCIN1 transcript, which encodes the p140Cap protein (Source: UniProt Q9C0H9). This region contains multiple binding sites for microRNAs (miRNAs) that post-transcriptionally regulate the expression of SRCIN1, a known inhibitor of Src family kinases. In various malignancies, such as breast and gastric cancers, overexpression of specific miRNAs like miR-150 or miR-211 leads to the downregulation of SRCIN1 via its 3'-UTR, thereby promoting tumor cell proliferation, migration, and invasion (Source: PubMed 25633788, 28415714). Consequently, the SRCIN1 mRNA 3'-UTR serves as a significant focal point for therapeutic intervention, where antisense oligonucleotides or miRNA inhibitors can be used to restore SRCIN1 levels. Beyond oncology, this regulatory region plays a role in synaptic plasticity and neurological health by modulating p140Cap expression in the brain (Source: PubMed 23103810). Understanding the interaction between the 3'-UTR and its regulatory ligands is essential for developing targeted RNA-based therapies.
MicroRNA-mediated gene silencing through complementary binding to the 3'-UTR, leading to mRNA degradation or translational repression.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRC kinase signaling inhibitor 1 mRNA 3'-untranslated region (SRCIN1 mRNA 3'-UTR).